Expert Practice in Breast Cancer

Meeting Overview
We are pleased to invite you to the Expert Practice^SM in Breast Cancer meeting in Lisbon, Portugal, on 2 April 2011. During this case-based meeting, leaders in the field discuss with participants, in an interactive format, clinical issues encountered daily by practicing physicians. For available travel grants, please contact: travelgrants@prIMEoncology.org

Location
Fontana Park Hotel R. Eng. Vieira da Silva 2 1050-105 Lisbon, Portugal

Target Audience
This educational activity is designed for Pan-European medical oncologists, radiation oncologists, surgical oncologists, and other healthcare providers actively involved in the management of patients with breast cancer.

Learning Objectives
Summarize the clinical challenges in the management of patients with breast cancer Review recent clinical advances in the treatment of breast cancer including novel combination regimens Discuss specific clinical settings and the factors that may contribute to improved patient outcomes Identify therapeutic strategies to optimize outcomes for patients with breast cancer

Faculty

Chair:

Fatima Cardoso, MD
Champalimaud Cancer Center

Lisbon, Portugal

Moderator:

Bojana Pajk, MD

prIME Oncology

The Hague, the Netherlands

Faculty:
Laura Biganzoli, MD

Hospital of Prato

Istituto Toscano Tumori

Prato, Italy

Michael Gnant, MD

Medical University of Vienna

Vienna, Austria

Antonio Llombart Cussac, MD, PhD

Hospital Universitario Arnau de Vilanova

Lleida, Spain

Agenda

Friday, 1 April 2011
20.00		Reception followed by buffet dinner
Saturday, 2 April 2011
08.30		Welcome, introduction, and demographics Fatima Cardoso, MD and Bojana Pajk, MD
08.50		Keynote Lecture Practice-changing information for management of breast cancer in 2011 Fatima Cardoso, MD
09.15		Case #1 Neoadjuvant treatment strategies for T3 breast cancer Michael Gnant, MD
09.55		Case #2 Endocrine-responsive early breast cancer: Is chemotherapy needed? Laura Biganzoli, MD
10.35		Break
10.55		Hot topic: What is the role of bone-targeted therapy in early breast cancer? Michael Gnant, MD
11.30		Case #3: Endocrine-responsive metastatic breast cancer Antonio Llombart Cussac, MD, PhD
12.10		Case#4: Management of HER2-negative progressive breast cancer Fatima Cardoso, MD
12.50		Lunch
13.50		Clinical opinion poll questions: Challenging the experts Faculty Panel
14.20		Case #5: Triple-negative breast cancer in the very young patient: Evaluating treatment options Laura Biganzoli, MD
15.00		Case #6: HER2-positive metastatic breast cancer: Opportunities and challenges Antonio Llombart Cussac, MD, PhD
15.40		Concluding remarks Fatima Cardoso, MD and Bojana Pajk, MD

Downloadable Slides

Case #1
Neoadjuvant treatment strategies for T3 breast cancer
Michael Gnant, MD

Case #2
Endocrine-responsive early breast cancer: Is chemotherapy needed?
Laura Biganzoli, MD

Case #3
Endocrine-responsive metastatic breast cancer
Antonio Llombart Cussac, MD, PhD

Case#4
Management of HER2-negative progressive breast cancer
Fatima Cardoso, MD

Case #5
Triple-negative breast cancer in the very young patient: Evaluating treatment options
Laura Biganzoli, MD

Case #6
HER2-positive metastatic breast cancer: Opportunities and challenges
Antonio Llombart Cussac, MD, PhD

Hot Topic
What is the role of bone-targeted therapy in early breast cancer?
Michael Gnant, MD

Keynote Lecture
Practice-changing information for management of breast cancer in 2011
Fatima Cardoso, MD

Print Materials

Accreditation
Expert Practice^SM in Breast Cancer has been awarded the ESMO label and 6 ESMO-MORA Category 1 points. Participants will receive a certificate of attendance at the conclusion of the activity.